Pyridinylimidazoles as dual glycogen synthase kinase 3β/p38α mitogen-activated protein kinase inhibitors
Heider, Fabian
, Ansideri, Francesco, Tesch, Roberta, Pantsar, Tatu, Haun, Urs, Döring, Eva, Kudolo, Mark, Poso, Antti , Albrecht, Wolfgang, Laufer, Stefan A. and Koch, Pierre
(2019)
Pyridinylimidazoles as dual glycogen synthase kinase 3β/p38α mitogen-activated protein kinase inhibitors.
European Journal of Medicinal Chemistry 175, pp. 309-329.
Date of publication of this fulltext: 03 Sep 2021 09:56
Article
Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | European Journal of Medicinal Chemistry | ||||
| Publisher: | ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER | ||||
|---|---|---|---|---|---|
| Place of Publication: | ISSY-LES-MOULINEAUX | ||||
| Volume: | 175 | ||||
| Page Range: | pp. 309-329 | ||||
| Date | 2019 | ||||
| Institutions | Chemistry and Pharmacy > Institute of Pharmacy Chemistry and Pharmacy > Institute of Pharmacy > Pharmaceutical/Medicinal Chemistry II (Prof. Buschauer) | ||||
| Identification Number |
| ||||
| Keywords | CYTOKINE UP-REGULATION; P38 MAP KINASE; SYNAPTIC DYSFUNCTION; P38-ALPHA MAPK; IMIDAZOLES; IDENTIFICATION; OPTIMIZATION; PREDICTION; MOLECULES; ASSAY; Kinase inhibitors; Pyridinylimidazoles; Glycogen synthase kinase 3 beta; p38 alpha MAP kinase; Dual inhibitors; Alzheimer's disease | ||||
| Dewey Decimal Classification | 500 Science > 540 Chemistry & allied sciences 600 Technology > 615 Pharmacy | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Yes | ||||
| Item ID | 48439 |
Export bibliographical data
Owner only: item control page
Altmetric
Altmetric